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Grant number: AI32880-02 
Project number: G-32-640 
Principal investigator: cindy A. Bohan 
organization: Georgia Institute of Technology 
Project Title: The Role of Tat in BIV Transcription Initiation 
1. Specific Aims 
HIV-1 . Tat is unique among eukaryotic transcription 
transactivators by virtue of its ability to bind specifically to 
TAR RNA sequences and to activate both initiation and elongation 
events during HIV transcription. The general objective of this 
proposal is to elucidate the molecular mechanisms of Tat 
transactivation during transcription initiation. Localization of 
discrete Tat functional domains active in transcription initiation, 
dissection of the mechanism{s) by which Tat enhances preinitiation 
complex formation during HIV transcription, and determination of 
Tat-mediated effects on the synthetic step of transcription 
initiation are the specific aims of this proposal. 
Aim 1: To localize discrete Tat functional domains active in 
transcription initiation. 
(a) by site-directed and deletion mutagenesis of Tat and by 
evaluation of Tat mutants on HIV transcription at different stages 
of preinitiation and initiation 
{b) by construction and evaluation of Gal4/Tat fusion proteins for 
their effect on HIV transcription in vivo and in vitro 
Aim 2: To dissect the mechanism(s) by which Tat stimulates the 
assembly of preinitiation complexes during BIV transcription. 
{a) by determination of association and disassociation rates of 
preinitiation complex assembly using gel shift and footprinting 
assays 
(b) by determination of Tat-protein interactions using 
coimmunoprecipitation analysis, cosedimentation analysis, protein 
filter binding and Tat-affinity chromatography 
(c) by determination of Tat effects on functional activities of 
preinitiation complex components 
Aim 3: To determine whether Tat affects the kinetics of productive 
initiation complex formation. 
2. studies and Results 
Aim 1: To localize discrete Tat functional domains active in 
transcription initiation 
During the last and current budget periods, we have obtained 
from collaborators and/or generated 25 site-directed and deletion 
mutant Tat cDNAs. The mutations span regions within Tat that have 
previously been implicated in Tat-specific transactivation of HIV 
LTR-directed gene expression in vivo. The wt and mutant Tat cDNAs 
have been subcloned into eukaryotic (pCMV) and prokaryotic (pet 
25b) expression vectors. These recombinant clones have been 
confirmed by dideoxynucleotide sequencing. To characterize the 
specific Tat mutants for their ability to transactivate HIV-LTR-
directed gene expression in vivo, wt and mutant Tat expression 
vectors have been cotransfected with an HIV LTR-CAT reporter 
plasmid into HeLa and Jurkat cells by calcium-phosphate 
precipitation and electroporation techniques, respectively. As 
predicted, the Tat domains encompassing the acidic, cysteine-rich 
and basic regions are required for transactivation of HIV LTR-
directed expression of the CAT gene. Although these initial 
studies offer little novel revelations on the mechanism of Tat 
transactivation at the level of transcription initiation, they are 
essential for establishing a comparative means of characterizing wt 
and mutant Tat recombinant proteins that we are in the process of 
purifying from ~ coli. These recombinant proteins used in in 
vitro transcription assays outlined within the grant should be 
helpful in identifying putative initiation- and elongation-specific 
functional domains in Tat. 
Aim 2: To 4issect the aechanism(s) by which Tat stimulates the 
assembly of preinitiation complexes 4urinq BIV transcription 
Recently, we published data (presented as preliminary studies 
for the original grant proposal) revealing Tat's role in 
facilitating the initial stages of HIV transcription preinitiation 
complex formation. Subsequent and confirmatory to our initial 
observations, Tat has been shown to interact directly with TFIID 
and to stabilize HIV LTR-specific TFIID-TATA binding in vitro (J. 
Brady, personal communications). During the last and current 
budget periods, we have focused our efforts to establish mechanisms 
to determine whether or not the interaction of Tat with core 
transcription initiation complex components, such as TFIID, is a 
functional association. Anticipating their efficacy in retrieving 
active transcription preinitiation complexes in vitro that may be 
qualitatively and quantitatively characterized, we standardized the 
use of biotinylated HIV LTR templates in in vitro transcription 
assays and found that the 5'-biotinylated HIV LTR templates 
efficiently supported fully active transcription in nuclear run-off 
analyses. 
Considering the possible differential involvement of the TATA, 
initiator (Inr) and TAR elements within the HIV LTR in the 
formation of Tat-responsive and Tat-unresponsive transcription 
preinitiation complexes, we have begun extentive mutagenesis of the 
LTR within these regions. These mutant LTR constructs, tested 
both in vivo and in vitro for their responsiveness to Tat-specific 
transactivation, should prove to be invaluable for defining 
differences in basal versus activated preinitiation complexes and 
their respective efficiencies to convert to processive elongation-
competent transcription complexes. 
Aia 3: To 4eteraine whether Tat affects the kinetics of productive 
initiation coaplax foraation. 
Conversion of transcription preinitiation complexes to 
actively initiated complexes is a multi-step process. One such 
step, which has been described for some promoters, is the 
phosphorylation of the carboxy-terminal domain (CTD) of RNA 
polymerase II (RNAPII). During the last and current budget 
periods, we set forth to determine ultimately whether or not Tat 
affects, indirectly or directly, the phosphorylation of the CTD of 
RNAPII and thus potentiates enhanced conversion of HIV-specific 
transcription preinitiation to actively initiated, elongation-
competent complexes. In our initial attempts to standardize the 
methodology, we immunoprecipitated RNAPII (using CTD-specific 
antibodies) from HIV-specific basal transcription complexes that 
were synthesized in the presence of Hela cell-free extracts and P-
ATP and that were stalled selectively at preinitiation and after 
active initiation to assess qualitative alterations in the 
phosphorylation patterns of the CTD during transition from 
preinitiation to active initiation. These experiments proved to be 
unsuccessful as abundant non-specifically phosphorylated proteins 
present in the immunoprecipitate caused extremely high background 
interference. To overcome this technical problem, we have been 
standardizing the use of biotinylated promoter templates in in 
vitro transcription assays to isolate initially only those _proteins 
associated stably with the transcription complexes prior to 
phosphorylation and immunoprecipitation. Although no conclusive 
results may be reported to date, these templates have proved to be 
useful in reducing background interference. 
3. Siqnificance 
The genome of human immunodeficiency virus (HIV), the 
etiological agent of acquired immunodeficiency syndrome (AIDS), 
encodes, in addition to the common retroviral structural gene 
products, two essential regulatory proteins Tat and Rev. Tat, a 
16-kd RNA-binding protein is localized primarily to the nucleolus 
and acts as a potent activator of HIV long terminal repeat (LTR)-
directed gene expression to increase the steady-state levels of all 
HIV mRNAs. Since Tat activates HIV transcription at the levels of 
initiation and elongation, clearly understanding how Tat 
accomplishes either or both activities in the context of the 
integrated proviral genomes in latent and productive infections 
would be significant to the molecular biology of both eukaryotic 
transcription and retroviruses. Characterization of the role of 
Tat in the initial steps of transcription initiation and the 
interactions of Tat with basal transcription factors and/or 
cellular transactivator proteins as presented in this proposal 
should foster refinement of the complex biochemical nature of gene 
transcription. Further, these studies should illuminate the role 
of Tat in HIV gene regulation and provide more insight into the 
dynamics of Tat and cellular processes in the establishment and 
maintenance of HIV chronic latent and acute productive infections. 
4. Plans 
Aim 1: To localize discrete Tat functional domains active in 
transcription initiation 
During the next budget period, we will continue 
characterizing the HPLC-purified recombinant Tat mutant proteins 
for their biological activities, including stimulation of HIV LTR-
directed gene expression in vivo and of AIDS-associated Kaposi's 
Sarcoma (KS) cell growth, as well as for their abilities to 
facilitate HIV-specific preinitiation complex assembly in vitro. 
Additionally, we plan to construct and evaluate GAL4/Tat fusion 
proteins with LTR and derivative templates for their effect on 
transcription in yivo and in vitro. The LTR mutants that we are 
preparing currently will be useful in these studies. 
Aim 2: Dissection of the mechanism by which Tat stimulates the 
assembly of preinitiation complexes durinq BIV transcription 
Mutant HIV LTR templates, currently being generated, will be 
added to in vitro transcription reactions containing 0.015% 
sarkosyl in the presence or absence of Tat to identify promoter 
sequences that are required for both basal and Tat-responsive 
preinitiation complex formation. To determine whether Tat enhances 
the stability of the formed preinitiation complexes and, therefore, 
increases the effective concentration of complexes available for 
productive initiation, pulse-chase experiments using preinitiation 
complexes preformed on biotinylated and radiolabeled LTR templates 
and excess amounts of cold HIV LTR DNA will be performed in the 
absence or presence of Tat. Aliquots of preformed preinitiation 
complexes will be removed and purified at various times following 
addition of excess wt and mutant LTR DNAs and separated on native 
polyacrylamide gels. Dissociation rates for these gel-shifted 
complexes will be determined to assess the qualitative and 
quantitative effects of Tat on complex assembly and complex 
stability. 
Following in vivo and in vitro characterization of wt and 
mutant recombinant Tat proteins, we will begin investigating 
whether a direct interaction between Tat and components of 
preinitiation complexes exists by Tat-affinity chromatography. 
Should such an interaction be demonstrated, we will pursue testing 
the functionality of the interaction as outlined within the 
original proposal, utilizing the biotinylated HIV LTR templates 
standardized during this current budget period. 
Aim 3: Determination of whether Tat affects the kinetics of 
productive initiation complex foraation 
We plan to continue our efforts towards determining whether 
phosphorylation of RNA polymerase CTD is an essential event in HIV 
transcription. If CTD phosphorylation proves to be required for 
efficient conversion of HIV preinitiation complexes to active 
initiation complexes that are fully processive, we will perform 
experiments, standardized during this current budget year and 
presented above, in the presence or absence of Tat to examine 
whether Tat mediates an effect on CTD phosphorylation. 
s. Ruman SUbjects 
None 
6. Vertebrate Aniaala 
We obtained an IACAUC control number (03-93) from the 
Institute Animal care and Use Committee at Georgia Tech (Chair: Jim 
Toler) July 14, 1993 for the purpose of generating epitope-specific 
anti-Tat monoclonal antibodies in mice. All animal work was 
performed by Dr. John Morrow at Texas Tech University Health 
Sciences Center in Lubbock, TX under a consortium/contractual 
agreement. The work for this contract was completed September 1, 
1993. 
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a. Inventions and Patents 
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The remaining funds will be transferred to Tulane University 
Medical Center. 
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